Histopathologic features and MIB-1 labeling indices in recurrent and nonrecurrent meningiomas

被引:0
|
作者
Abramovich, CM [1 ]
Prayson, RA [1 ]
机构
[1] Cleveland Clin Fdn, Dept Anat Pathol L25, Cleveland, OH 44195 USA
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background.-Predicting the behavior of meningiomas based on histopathologic features alone has remained problematic. Design.-This study retrospectively compared several histopathologic features and MIB-1 labeling indices (LIs) in recurrent meningiomas with those of nonrecurrent meningiomas. Six histopathologic features, including mitoses, necrosis, loss of architectural pattern, hypervascularity/hemosiderin deposition, prominent nucleoli, and nuclear pleomorphism, were compared between 32 recurrent and 27 nonrecurrent meningiomas using Fisher exact tests. MIB-1 LIs (% positive tumor cell nuclei) were compared using the Wilcoxon rank sum test. Results.-The patients in the recurrent group included 26 women (mean age, 55 years), who developed 1 to 5 recurrences. Time intervals to the first recurrence ranged from 5 to 183 months (mean, 55 months). The nonrecurrent group included 21 women (mean age, 56 years), with follow-up ranging from 88 to 124 months (mean, 109 months). Of the histopathologic features evaluated, statistically significant differences between the recurrent and nonrecurrent groups were found only with respect to prominent nucleoli (P = .024) and nuclear pleomorphism (P < .001), both of which were more common in the recurrent group. In the recurrent group, 9 tumors were considered malignant (defined by brain invasion or metastasis) versus 2 of the nonrecurrent meningiomas. Nineteen percent of nonrecurrent tumors versus 41% of recurrent tumors had 2 or more of the 6 histopathologic features. MIB1 LIs in the nonrecurrent group ranged from 0 to 8.3 (mean, 1.5) and were generally lower than those in the recurrent group (range, 0-32.5; mean, 5.4); no statistical difference was identified between these groups. No statistically significant difference with regard to histology or MIB-1 ils was noted between the initially excised recurrent tumor and the most recently resected recurrence. Conclusions.-Of the histopathologic features examined, only prominent nucleoli and nuclear pleomorphism were found to be statistically more common in recurrent than nonrecurrent meningiomas. The mean MIB-1 LI was higher in the recurrent than in the nonrecurrent group, although there was no statistical difference between means and there was clear overlap with regard to MIB-1 LI ranges.
引用
收藏
页码:793 / 800
页数:8
相关论文
共 50 条
  • [41] Cyclin D1 (CD1) expression and MIB-1 labeling indices (L1) in ependymomas.
    Prayson, RA
    MODERN PATHOLOGY, 1998, 11 (01) : 161A - 161A
  • [42] Prognostic significance of Ki-67/MIB-1 proliferation index in meningiomas
    Torp, SH
    Lindboe, CF
    Gronberg, BH
    Lydersen, S
    Sundstrom, S
    CLINICAL NEUROPATHOLOGY, 2005, 24 (04) : 170 - 174
  • [43] Viral and histopathologic correlates of MN and MIB-1 expression in cervical intraepithelial neoplasia
    Resnick, M
    Lester, S
    Tate, JE
    Sheets, EE
    Sparks, C
    Crum, CP
    HUMAN PATHOLOGY, 1996, 27 (03) : 234 - 239
  • [44] bcl-2 and MIB-1 labeling indexes in cats with lymphoma
    Dank, G
    Lucroy, MD
    Griffey, SM
    Gandour-Edwards, R
    Madewell, BR
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2002, 16 (06) : 720 - 725
  • [45] Prognostic and therapeutic implications of the MIB-1 labeling index in breast cancer
    Nakagomi H.
    Miyake T.
    Hada M.
    Hagiwara J.
    Furuya K.
    Muto S.
    Koshizuka K.
    Takano K.
    Kato R.
    Imamura K.
    Oyama T.
    Tada Y.
    Breast Cancer, 1998, 5 (3) : 255 - 259
  • [46] MIB-1 labeling index predicts recurrence in intraventricular central neurocytomas
    Kaur, Gurvinder
    Kane, Ari J.
    Sughrue, Michael E.
    Oh, Michael
    Safaee, Michael
    Sun, Matthew
    Tihan, Terik
    McDermott, Michael W.
    Berger, Mitchel S.
    Parsa, Andrew T.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2013, 20 (01) : 89 - 93
  • [47] Lack of prognostic significance of an optimized MIB-1 labeling index.
    Grzybicki, DM
    Liu, YL
    Brown, HG
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (05): : 517 - 517
  • [48] EXTRAVENTRICULAR NEUROCYTOMA WITH MIB-1 LABELING INDEX OVER 10% IN A CHILD
    Messina, R.
    Zambuto, M.
    Calace, A.
    De Tommasi, A.
    NEURO-ONCOLOGY, 2012, 14 : 67 - 67
  • [49] Proliferative potentials of meningiomas analyzed by MIB-1 staining index and tumor doubling time
    Matsuno, A
    Nakaguchi, H
    Nagashima, T
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2004, 52 : S38 - S38
  • [50] Extracranially extended meningothelial meningiomas with a high MIB-1 index: A report of two cases
    Yamada, SM
    Yamada, S
    Takahashi, H
    Teramoto, A
    Matsumoto, K
    NEUROPATHOLOGY, 2004, 24 (01) : 66 - 71